Risk Factors for Postherpetic Neuralgia
Authors:
- Karin GalilKGKarin Galil
- James G. DonahueJDJames G. Donahue
- Alexander M. WalkerAWAlexander M. Walker
- Donna SpiegelmanDSDonna Spiegelman
- Richard PlattRPRichard Platt
- 9 June 1997
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 157 (11) , 1217-1224
Abstract
Background: The risk factors for postherpetic neuralgia (PHN), the most common complication of herpes zoster, have not been well established. Objective: To elucidate the risk factors for PHN. Methods: Automated medical, claims, and pharmacy records of a health maintenance organization were used to identify cases of PHN and obtain data on risk factors. A case-base design was used to assess the impact of various patient, disease, and treatment factors on the prevalence of PHN 1 and 2 months after developing zoster. Results: There were 821 cases of herpes zoster that met all eligibility criteria. The prevalence of PHN more than 30 days after onset of zoster was 8.0% (95% confidence interval [CI], 6.3%-10.1%) and 4.5% (95% CI, 3.2%6.2%) after 60 days. Compared with patients younger than 50 years, individuals aged 50 years or older had a 14.7-fold higher prevalence (95% CI, 6.8-32.0) 30 days and a 27.4-fold higher prevalence (95% CI, 8.8-85.4) 60 days after developing zoster. Prodromal sensory symptoms and certain conditions associated with compromised immunity were also associated with PHN. Systemic corticosteroids before zoster and treatment of zoster with acyclovir or corticosteroids did not significantly affect the prevalence of PHN. Conclusions: Increased age and prodromal symptoms are associated with higher prevalence of PHN 1 and 2 months after onset of zoster. Overall, systemic acyclovir appears not to confer any protection against PHN, although benefit among elderly patients cannot be excluded. Arch Intern Med. 1997;157:1217-1224Keywords
This publication has 29 references indexed in Scilit:
- The sequelae of herpes zosterArchives of internal medicine (1960), 1997
- Postherpetic Neuralgia — Pathogenesis, Treatment, and PreventionNew England Journal of Medicine, 1996
- Chronic opioid therapy as alternative treatment for post-herpetic neuralgiaAnnals of Neurology, 1994
- Other neurological complications of herpes zoster and their managementAnnals of Neurology, 1994
- Hypotheses on the pathogenesis of herpes zoster?associated painAnnals of Neurology, 1994
- Overview: The biology of varicella-zoster virus infectionAnnals of Neurology, 1994
- A Randomized Trial of Acyclovir for 7 Days or 21 Days with and without Prednisolone for Treatment of Acute Herpes ZosterNew England Journal of Medicine, 1994
- Herpes zoster: A comparative study of general practitioner and patient experienceCurrent Medical Research and Opinion, 1994
- A new topical treatment for acute herpetic neuralgia and post-herpetic neuralgia: the aspirin/diethyl ether mixture. An open-label study plus a double-blind controlled clinical trialPain, 1992
- Topical capsaicin treatment of chronic postherpetic neuralgiaJournal of the American Academy of Dermatology, 1989